|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��¶���ǽ�������� |
|
���� |
|
Ƥ������ |
| ��������������� | |
|
����ΰ |
|
���Ǹ� |
| PubMed | |
|
Article by |
|
Article by |
��¶���ǽ�������ؼ�����Ƥ�����Ĺ�ϵ
����ΰ, ���Ǹ�
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧ����Э��ҽԺƤ����, ����100730
��¶���ǽ����������һ���ɸ�����ڵ�Ѫ��������,�����������ϸ���Ͳ�������ĸ�¶�Dzл����,���Ҽ����C3,�������ķ�����Ӧ����¶���ǽ�������صĻ�����ж�̬��,�ڸ�¶���ǽ�������ػ������ĸ���Ѫ���г��ֵ�Ũ�ȸ�¶���ǽ��������,����û��,��ʱ�����������Ⱦ,��������ȱ�ݲ��������ɫ�����������Ѫ��������������Ⱦ��������ԡ�
[2] Super M, Thiel S, Lu J, et al. Association of low levels of mannanbinding protein with a common defect of opsonisation. Lancet, 1989,2:1236-1239.
[3] Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol, 2001, 38:133-149.
[4] Sumiya M, Super M, Tabona P, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet, 1991, 337:1569-1570.
[5] Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta, 2002, 1572:401-413.
[6] Nielsen SL, Andersen PL, Koch C, et al. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients.Clin Exp Immunol, 1995, 100:219-222.
[7] Garred P, Madsen HO, Balslev U, et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannosebinding lectin. Lancet, 1997, 349:236-240.
[8] Kelly P, Jack DL, Naeem A, et al. Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. Gastroenterology, 2000, 119:1236-1242.
[9] Tang YW, Cleavinger PJ, Li H, et al. Analysis of candidate-host immunogenetic determinants in herpes simplex virus-associated Mollaret's meningitis. Clin Infect Dis, 2000, 30:176-178.
[10] Neth O, Jack DL, Dodds AW, et al. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun, 2000, 68:688-693.
[11] Gulati S, Sastry K, Jensenius JC, et al. Regulation of the mannanbinding lectin pathway of complement on Neisseria gonorrhoeae by C1-inhibitor and alpha 2-macroglobulin. J Immunol, 2002, 168:4078-4086.
[12] Babula O, Lazdane G, Kroica J, et al. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin Infect Dis, 2003, 37:733-737.
[13] Richardson VF, Larcher VF, Price JF. A common congenital immunodeficiency predisposing to infection and atopy in infancy. Arch Dis Child, 1983, 58:799-802.
[14] Lau YL, Lau CS, Chan SY, et al. Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum,1996, 39:706-708.
[15] Garred P, Madsen HO, Halberg P, et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum, 1999, 42:2145-2152.
[16] Seelen MA, Trouw LA, van der Hoorn JW, et al. Autoantibodies against mannose-binding lectin in systemic lupus erythematosus. Clin Exp Immunol, 2003,134:335-343.
[17] Wang ZY, Morinobu A, Kanagawa S, et al. Polymorphisms of the mannose binding lectin gene in patients with Sjogren's syndrome. Ann Rheum Dis, 2001,60:483-486.
[18] Vorup-Jensen T, Sorensen ES, Jensen UB, et al. Recombinant expression of human mannan-binding lectin. Int Immunopharmacol,2001, 1:677-687.